Recentguidelines recommend considering use of metformin in patients with prediabetes (fasting plasma glucose 100-125 mg/dL, 2-hr post-load glucose 140-199 mg/dL, or A1C %), especially in those who are 35 kg/m, or have a history of gestational diabetes. Metformin has not been approved for such use by the FDA.

MetforminTeva tablets can be used in children from 10 years of age and adolescents. The usual starting dose is one tablet of 500 mg or 850 mg once daily, given during meals or after meals. After 10 to 15 days the should be adjusted on the basis of blood glucose measurements. A slow increase of dose may improve gastrointestinal tolerability.

Metformins most common use is as a first-line treatment for type 2 diabetes. Metformin increases insulin sensitivity and has been demonstrated to have a wide range of other health benefits. Increasingly, metformin is being prescribed for people with prediabetes, gestational diabetes, type 1 diabetes, and polycystic ovary syndrome (PCOS).
Theapparent volume of distribution (V/F) of metformin following single oral doses of 850 mg averaged 654±358 L. Metformin is negligibly bound to plasma proteins. Metformin partitions into erythrocytes, most likely as a function of time. At usual clinical doses and dosing schedules of metformin, steady state plasma concentrations of metformin
Therecommended dose in adults is 500 mg or 850 mg Metformin Mylan two or three times a day. The maximum daily dose is 3000 mg taken as 3 divided doses. If you take insulin too, your doctor will tell you how to start Metformin Mylan. Use in children 10 years of age and over and adolescents . 375 17 43 476 239 262 145 214

what is metformin 850 mg used for